Yesterday, the COO of Invitae (NYSE: NVTA), Lee Bendekgey, sold shares of NVTA for $44.46K.
In addition to Lee Bendekgey, 3 other NVTA executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Invitae’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $27.67 million and GAAP net loss of $36.12 million. In comparison, last year the company earned revenue of $10.34 million and had a GAAP net loss of $26.93 million. Currently, Invitae has an average volume of 2.18M.
The insider sentiment on Invitae has been positive according to 12 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headuartered in San Francisco, CA.
